Mono- vs. Bis-Guanyl Hydrazone-Decorated Tricyclic Scaffolds: Effects on G-Quadruplex Binding and Selectivity
International Journal of Molecular Sciences · 10.06.2026 · 27 (12) · 5282
DOI: 10.3390/ijms27125282 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 10.06.2026. Verfasst von Chiara Platella und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Chemical Sciences, University of Naples Federico II, Via Cintia 21, 80126 Naples, Italy. Hauptthemen laut MEDLINE: G-Quadruplexes, Hydrazones, Antineoplastic Agents. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Italian Association for Cancer Research, European Union, Fondazione AIRC.
Abstract (Originalsprache)
Mono- and bis-guanyl hydrazone-functionalized tricyclic compounds were here designed and investigated as putative G-quadruplex ligands in the context of anticancer drug development. The G-quadruplex on Controlled Pore Glass (G4-CPG) assay, a fast and easy screening method based on affinity chromatography for identifying potential G-quadruplex binders, together with biophysical techniques such as circular dichroism and fluorescence spectroscopy, demonstrated a higher selectivity of mono- with respect to disubstituted derivatives in recognizing G-quadruplexes from telomeric and oncogenic DNA regions vs. duplexes. Among the mono-substituted compounds, higher G-quadruplex selectivity was found for those containing the pyrido [3,4-b]indole and dibenzofuran scaffolds compared to the 9H-fluorene, 9H-carbazole, and dibenzothiophene ones. Molecular docking studies suggested that the investigated ligands bound the hybrid telomeric G-quadruplex model by adopting a coplanar arrangement of the core and guanyl hydrazone moieties, both stacked on the 5′-G-quartet, while in the interaction with the parallel oncogenic G-quadruplex model the guanyl hydrazone moieties pointed towards the grooves/loops. Finally, biological assays highlighted the higher potential of mono-guanyl hydrazone-derivatized tricyclic compounds as selective anticancer agents, showing higher anticancer activity and selectivity of action than the bis-guanyl hydrazone derivatives.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Chemical Sciences, University of Naples Federico II, Via Cintia 21, 80126 Naples, Italy.
- Department of Chemistry, University of Milan, Via Golgi 19, 20133 Milan, Italy.
- Institute of Biostructure and Bioimaging (IBB), National Research Council (CNR), 80145 Naples, Italy.
ORCID-Profile: Chiara Platella, Giovanni Cipolla, Rosa Gaglione, Angela Arciello, Pierfausto Seneci, Domenica Musumeci, Alessandra Silvani, Clelia Giannini, Daniela Montesarchio
Förderung
- Italian Association for Cancer Research
- European Union
- Fondazione AIRC
Zitieren
APA
Platella, C., Maiocchi, A., Cipolla, G., Gaglione, R., Arciello, A., Seneci, P., Musumeci, D., Silvani, A., Giannini, C., & Montesarchio, D. (2026). Mono- vs. Bis-Guanyl Hydrazone-Decorated Tricyclic Scaffolds: Effects on G-Quadruplex Binding and Selectivity. International Journal of Molecular Sciences, 27(12), 5282. https://doi.org/10.3390/ijms27125282
Vancouver
Platella C, Maiocchi A, Cipolla G, Gaglione R, Arciello A, Seneci P, et al. Mono- vs. Bis-Guanyl Hydrazone-Decorated Tricyclic Scaffolds: Effects on G-Quadruplex Binding and Selectivity. International Journal of Molecular Sciences. 2026;27(12):5282. doi:10.3390/ijms27125282
BibTeX
@article{Platella2026,
author = {Platella, Chiara and Maiocchi, Alice and Cipolla, Giovanni and Gaglione, Rosa and Arciello, Angela and Seneci, Pierfausto and Musumeci, Domenica and Silvani, Alessandra and Giannini, Clelia and Montesarchio, Daniela},
title = {Mono- vs. Bis-Guanyl Hydrazone-Decorated Tricyclic Scaffolds: Effects on G-Quadruplex Binding and Selectivity},
journal = {International Journal of Molecular Sciences},
year = {2026},
volume = {27},
number = {12},
pages = {5282},
doi = {10.3390/ijms27125282}
}
EUVIMED